Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

CureVac NV (CVAC)

NASDAQ
Symbol
Exchange
Currency
CVACNASDAQUSD
1CVACMilanEUR
5CVXetraEUR
5CVTradeGateEUR
5CVFrankfurtEUR
CVACViennaEUR
Currency in USD
Disclaimer
2.310
-0.200(-7.97%)
Closed
Pre Market
2.330+0.020(+0.87%)

CVAC Comments

soon 90..
not today
What happens in pre?
https://finance.yahoo.com/news/eu-regulator-does-not-expect-121745415.html
thanks
huge drop today, any news that cause this ?
approval is 2 month postponed
what happened?
https://finance.yahoo.com/news/eu-regulator-does-not-expect-121745415.htmlThe European Medicines Agency (EMA) does not expect to make a decision on the approval of German biotech group CureVac's COVID-19 vaccine before August, an off...
Approval...this week???
I hope so.... 🤞
Greatings from Germany. I guess it is a matter of days until we see the next move. As soon as we get some news in, the stock will follow the valuations of Moderna and Biontech (in your country you say Pfizer for the vaccine, but in realty it is Biontech.Alsdo German. The valuation of Biontech is 2,3 times higher and Curevac has the same product as well a a very famous shareholder . At the End of the year we will see the same valutaion for both. My guess is arround 80-100 billion. Best
Thanks...I really hope you are right!
But the vaccine market is saturated now with the West nearly half vaccinated already.
Hope so. It is a solid company with a solid product (mRNA). Essentially same stuff as Biontech and Moderna. nice to meet you, dear neighbour.
New Highs on way
after this resistance the way look's clean
"Changes to international intellectual property rules require unanimous agreement" (...) ""The activists said a waiver alone would not increase the world’s vaccine supply. It must be accompanied by a process known as “tech transfer,” in which patent holders supply technical know-how and personnel." (...) “Handing needy countries a recipe book without the ingredients, safeguards and sizable work force needed will not help people waiting for the vaccine,” Dr. Michelle McMurry-Heath." (NYTIMES) I don't see that happening TBH. Just hard to imagine the cake will be shared or maybe I'm too cynical for this level of humanitarianism. Looking for a dip. What do you think?
is there a price action towards to correction of 20% from 130.50 now?
Biden killed vaccines related stocks with his his nonsense patent talk
He's 140 years old, not enough time to mandate anything. Yeah, I know, I couldn't resist
Pop pop
Are earnings tommorrow? There are different dates lying around. Cheers.
Hi, Giuseppe. It's a secret, and we are not allowed to reveal any info.
Schizophrenia plus trading must be fun
Buy buy 150 + coming
Why Zolex Zoka?
World no longer belive in AZN and JNJ ,and on the other side world needs more and more vaccines. CureVac already signed charging contract with Bayer,Sanofi, Novartis ...etc. They will produce most vaccines. I said too low price 150$ ,when they come out from phase III. it will be rocket ,see you then ;-)
Ok its true. I’m in, with 200 shares
ARCT is more or less the same?!
on June 1st 2021. price will hit 150 $ :-)
It will fly. Just buy
Best stock ever . If ya know how to trade
Worst stock ever
Buy buy buy
Target hit . Next 200
TP150
TP 95
Partnership with Tesla is good news during this dip.
https://www.google.com.sg/amp/s/www.businesstimes.com.sg/consumer/novartis-deal-bolsters-curevacs-vaccine-contractor-line-up?amp
TP 70
...
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.